Welcome to Cilag AG, Schaffhausen, Switzerland

Cilag AG is part of Janssen, the pharmaceuticals division of Johnson & Johnson*, and produces pharmaceutical and medical products and active ingredients. The company is a strategic market launch and manufacturing location for some of Johnson & Johnson’s most important pharmaceutical products. Using state-of-the-art technologies and processes, Cilag AG produces a variety of pharmaceutical dosage forms and active chemical ingredients. In addition, it also produces “ASP Cellblocks”  and Sterrad cassettes for the Johnson & Johnson subsidiary Advanced Sterilization Products (ASP). The products are used in hospitals and labs worldwide for the sterilization of medical and surgical equipment and instruments.

 

Cilag AG was established in Schaffhausen in 1936 and has been part of the Johnson & Johnson Family of Companies since 1959. In the 1990s in particular, the company expanded continuously through innovation, and today Cilag AG is one of the largest manufacturers in the Swiss pharmaceuticals industry. Cilag AG employs approximately 1,200 people.

 

 

*Johnson & Johnson groups its companies operating worldwide in the pharmaceutical sector under the “Janssen Pharmaceutical Companies of Johnson & Johnson” trademark. Since October 2015, Cilag AG’s market presence has been associated with the image of the Janssen trademark. By adopting the Janssen image, Cilag takes its long-standing membership of the Johnson & Johnson Group and its strategic significance within the Janssen Pharmaceutical Companies’ supply chain into account.

This site is published by Cilag AG which is solely responsible for its content.
It is intended for visitors from Switzerland.